Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
AstraZeneca
Colorcon
Merck
Baxter
Boehringer Ingelheim

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

VIOMYCIN SULFATE - Generic Drug Details

See Plans and Pricing

« Back to Dashboard

What are the generic sources for viomycin sulfate and what is the scope of patent protection?

Viomycin sulfate is the generic ingredient in one branded drug marketed by Pfizer and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There is one drug master file entry for viomycin sulfate.

Summary for VIOMYCIN SULFATE
US Patents:0
Tradenames:1
Applicants:1
NDAs:1
Drug Master File Entries: 1
Bulk Api Vendors: 5
Patent Applications: 41
DailyMed Link:VIOMYCIN SULFATE at DailyMed
Medical Subject Heading (MeSH) Categories for VIOMYCIN SULFATE
Synonyms for VIOMYCIN SULFATE
AC1MHWUU
CCG-213217
Celicomycin-sulfate
DTXSID60872306
Florimycin sulfate
HMS1571O08
LS-162213
NOCAS_872306
NSC-760360
NSC760360
Pharmakon1600-01503848
Solfato di viomicina [Italian]
Viocin sulfate
Viomycin mono sulfate
Viomycin-sulfat [German]
Viomycin, sulfate (salt)
Viomycinsulfat

US Patents and Regulatory Information for VIOMYCIN SULFATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer VIOCIN SULFATE viomycin sulfate INJECTABLE;INJECTION 061086-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer VIOCIN SULFATE viomycin sulfate INJECTABLE;INJECTION 061086-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Merck
McKinsey
Mallinckrodt
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.